Vitalia co-founders Niklas Anzinger and Laurence Ion today announced that they will be leading two new, separate organizations, Viva City and Infinita City. “Together, we built Vitalia from the ground up, establishing a foundation that has led us to this exciting new chapter,” said Anzinger and

BioAge Labs, Inc. (“BioAge”), a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging, today announced a multi-year research collaboration with Novartis. The collaboration aims to identify and validate multiple novel therapeutic drug targets by investigating the biological

Longevity Hackers, an in-depth look at how to slow the human pace of aging, debuts on Apple TV and Amazon beginning December 4, 2024. Produced by Ruben Figueres, directed by Michal Siewierski, and narrated by Academy Award nominee, Edward Norton, the film revolutionizes outdated cultural conceptions

Turn Biotechnologies, a cell rejuvenation and restoration company developing novel mRNA medicines for untreatable, age-related conditions, announced its latest study to assess the efficacy of using epigenetic reprogramming to rejuvenate bone marrow stem cells. The study, which is being funded by Methuselah Foundation, is the first

The Longevity Summit, a leading conference bringing together the complete ecosystem of longevity science and biotechnology, will hold its fourth annual event on December 3-4, 2024, at the Buck Institute for Research on Aging in Novato, California. This immersive two-day conference creates a unique peer-to-peer learning

Longevity Summit Dublin, the premier international event dedicated to the latest research, innovation, and collaboration in the field of longevity, is excited to announce its new dates and venue for 2025. The summit will take place from July 2-4, 2025, at the historic Trinity College Dublin

In a world first, a pig kidney preserved at subzero temperatures was successfully transported across the Atlantic Ocean multiple times, demonstrating the potential for a novel technology to greatly extend organ storage and preservation, and make long-distance organ transportation a clinical reality. Extending organ preservation time

The Longevity Science Foundation (LSF), a nonprofit organization dedicated to funding research aimed at extending the healthy human lifespan, is proud to announce a grant award to researchers at the University of Oxford’s Department of Physiology, Anatomy, and Genetics, within the Medical Sciences Division, for the

It might take a second renaissance bringing polymaths across science to solve aging and enhance human mental capacity to groundbreaking heights. This week’s Longevity, Computing, and Cognition Research Hackathon at MIT tackles this initiative. From 10/25 to 10/27, Ekkolápto, Augmentation Lab, and Meditation Artifacts will unite

Frontier Bio Corporation has announced a groundbreaking achievement in lab-grown lung tissue. By combining 3D bioprinting with the ability of stem cells to self-assemble, mimicking natural organ development, the California-based biotech company has created complex microscale lung tissue. This innovation paves the way for advancements in

The quest to extend human lifespan and improve healthspan is advancing rapidly, and one of the most prestigious platforms for driving these discussions is the Roundtable of Longevity Clinics. This annual gathering brings together global experts to exchange knowledge on cutting-edge research, innovations, and regulatory strategies

The Biomarkers of Aging Consortium is proud to announce its second annual Biomarkers of Aging Conference, scheduled for November 1-2, 2024, at the Joseph Martin Conference Center at Harvard Medical School. This event stands as the premier conference dedicated to all aspects of biomarkers of aging,

Insilico Medicine, a clinical-stage generative AI-driven drug discovery company, announced positive preliminary results from its Phase IIa clinical trial evaluating ISM001-055. ISM001-055 is a first-in-class small molecule targeting TNIK (Traf2- and Nck-interacting kinase) and was designed utilizing generative AI to treat idiopathic pulmonary fibrosis (IPF). The